58 related articles for article (PubMed ID: 21601197)
1. In vitro viability and secretory capacity of human luteinized granulosa cells after gonadotropin-releasing hormone agonist trigger of oocyte maturation.
Engmann L; Romak J; Nulsen J; Benadiva C; Peluso J
Fertil Steril; 2011 Jul; 96(1):198-202. PubMed ID: 21601197
[TBL] [Abstract][Full Text] [Related]
2. Effect of gonadotropin-releasing hormone agonist and antagonist on proliferation and apoptosis of human luteinized granulosa cells.
Vitale AM; Abramovich D; Peluffo MC; Meresman G; Tesone M
Fertil Steril; 2006 Apr; 85(4):1064-7. PubMed ID: 16580402
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin-releasing hormone antagonists do not influence the secretion of steroid hormones but affect the secretion of vascular endothelial growth factor from human granulosa luteinized cell cultures.
Asimakopoulos B; Nikolettos N; Nehls B; Diedrich K; Al-Hasani S; Metzen E
Fertil Steril; 2006 Sep; 86(3):636-41. PubMed ID: 16904114
[TBL] [Abstract][Full Text] [Related]
4. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
[TBL] [Abstract][Full Text] [Related]
5. Cumulus cells of oocyte-cumulus complexes secrete a meiosis-activating substance when stimulated with FSH.
Byskov AG; Yding Andersen C; Hossaini A; Guoliang X
Mol Reprod Dev; 1997 Mar; 46(3):296-305. PubMed ID: 9041132
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of gonadotrophin-releasing hormone (GnRH) on rat granulosa cell deoxyribonucleic acid synthesis.
Saragüeta PE; Lanuza GM; Barañao JL
Mol Reprod Dev; 1997 Jun; 47(2):170-4. PubMed ID: 9136118
[TBL] [Abstract][Full Text] [Related]
7. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles.
Griesinger G; Kolibianakis EM; Papanikolaou EG; Diedrich K; Van Steirteghem A; Devroey P; Ejdrup Bredkjaer H; Humaidan P
Fertil Steril; 2007 Sep; 88(3):616-21. PubMed ID: 17451691
[TBL] [Abstract][Full Text] [Related]
8. Variations in L-selectin ligand expression in the luteal-phase endometrium after final oocyte maturation with human chorionic gonadotropin compared with a gonadotropin-releasing hormone agonist.
Lipari CW; Zhao Y; King JA; Alexander CJ; Bankowski BB; Lai TH; Garcia J; Vlahos NP
Fertil Steril; 2008 Sep; 90(3):876-8. PubMed ID: 17765234
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: a rationale for OHSS reduction.
Cerrillo M; Rodríguez S; Mayoral M; Pacheco A; Martínez-Salazar J; Garcia-Velasco JA
Fertil Steril; 2009 Apr; 91(4 Suppl):1526-8. PubMed ID: 18990367
[TBL] [Abstract][Full Text] [Related]
10. Expression of bone morphogenetic protein-15 in human oocyte and cumulus granulosa cells primed with recombinant follicle-stimulating hormone followed by human chorionic gonadotropin.
Chen Y; Zhao S; Qiao J; Liu P; Lian Y; Zheng X
Fertil Steril; 2009 Dec; 92(6):2045-6. PubMed ID: 19635612
[TBL] [Abstract][Full Text] [Related]
11. Modulation of human granulosa cell steroid production in vitro by tumor necrosis factor alpha: implications of white blood cells in culture.
Best CL; Pudney J; Anderson DJ; Hill JA
Obstet Gynecol; 1994 Jul; 84(1):121-7. PubMed ID: 8008306
[TBL] [Abstract][Full Text] [Related]
12. Comparison of human chorionic gonadotropin and gonadotropin-releasing hormone agonist for final oocyte maturation in oocyte donor cycles.
Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Ross R
Fertil Steril; 2007 Jul; 88(1):237-9. PubMed ID: 17296193
[TBL] [Abstract][Full Text] [Related]
13. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study.
Humaidan P; Ejdrup Bredkjaer H; Westergaard LG; Yding Andersen C
Fertil Steril; 2010 Feb; 93(3):847-54. PubMed ID: 19200959
[TBL] [Abstract][Full Text] [Related]
14. Cryopreserved blastocyst transfer: impact of gonadotropin-releasing hormone agonist versus antagonist in the previous oocyte retrieval cycles.
Lee JR; Choi YS; Jee BC; Ku SY; Suh CS; Kim KC; Lee WD; Kim SH
Fertil Steril; 2007 Nov; 88(5):1344-9. PubMed ID: 17548083
[TBL] [Abstract][Full Text] [Related]
15. Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone.
Kolibianakis EM; Papanikolaou EG; Tournaye H; Camus M; Van Steirteghem AC; Devroey P
Fertil Steril; 2007 Nov; 88(5):1382-8. PubMed ID: 17445806
[TBL] [Abstract][Full Text] [Related]
16. Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study.
Griesinger G; von Otte S; Schroer A; Ludwig AK; Diedrich K; Al-Hasani S; Schultze-Mosgau A
Hum Reprod; 2007 May; 22(5):1348-52. PubMed ID: 17303632
[TBL] [Abstract][Full Text] [Related]
17. Follicular growth and oocyte maturation in GnRH agonist and antagonist protocols for in vitro fertilisation and embryo transfer.
Depalo R; Lorusso F; Palmisano M; Bassi E; Totaro I; Vacca M; Trerotoli P; Masciandaro P; Selvaggi L
Gynecol Endocrinol; 2009 May; 25(5):328-34. PubMed ID: 19340626
[TBL] [Abstract][Full Text] [Related]
18. Effects of gonadotropin-releasing hormone agonists and antagonists on luteal function.
DiLuigi AJ; Nulsen JC
Curr Opin Obstet Gynecol; 2007 Jun; 19(3):258-65. PubMed ID: 17495643
[TBL] [Abstract][Full Text] [Related]
19. GnRHa to trigger final oocyte maturation: a time to reconsider.
Humaidan P; Papanikolaou EG; Tarlatzis BC
Hum Reprod; 2009 Oct; 24(10):2389-94. PubMed ID: 19608565
[TBL] [Abstract][Full Text] [Related]
20. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome.
Scotti L; Irusta G; Abramovich D; Tesone M; Parborell F
Mol Cell Endocrinol; 2011 Mar; 335(2):116-25. PubMed ID: 21238536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
